Molecular Basis of Human Defensins as Novel Lipid II Binding Peptide Antibiotics
Molecular Basis of Human Defensins as Novel Lipid II Binding Peptide Antibiotics
批准号:
8320100
负责人:
Erik de Leeuw
金额:
$19.19万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-15 至 2014-07-31
关键词:
AcuteAnabolismAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic ResistanceAntibioticsBacteriaBacterial InfectionsBindingBiochemicalBiological AssayCell WallChargeClinicalDefensinsDevelopmentDisulfidesElectrostaticsFamilyFrequenciesGoalsGram-Positive BacteriaHost DefenseHumanInfectionKnowledgeLeadLightLipid BindingLipidsMembraneMolecularMulti-Drug ResistanceMutateMutationNatural ImmunityOutcomePatientsPeptide AntibioticsPeptidesPharmaceutical PreparationsPrevalencePreventionReportingResearchResistanceTherapeuticTimeValidationVirus Diseasesanalogantimicrobialantimicrobial drugantimicrobial peptidebacterial resistancebasecombatdisulfide bondfightinghuman neutrophil peptide 1infectious disease treatmentinnovationinsightkillingsmanmembrane biogenesismicrobialnovelpathogenresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The prevalence of resistant bacterial pathogens is rendering current antibiotics ineffective, and making it essential that new drugs be developed to fight infection. Defensins are antimicrobial peptides that protect man against bacterial and viral infections and have a wide range as potential anti-infective therapeutics. This proposal identifies Lipid II, an essential precursor in bacterial membrane biogenesis, as a potential target of defensin antibacterial activity for the first time. The overall objective of our study is to define functional and structural interactions between defensins and Lipid II. In the long term, we aim to apply the knowledge gained in our research towards the development of defensin-based antibiotic compounds targeting Lipid II to combat Gram-positive pathogenic infections.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.2147/dddt.s79504
发表时间:
2015
期刊:
Drug design, development and therapy
影响因子:
--
作者:
[Fletcher S, Yu W, Huang J, Kwasny SM, Chauhan J, Opperman TJ, MacKerell AD Jr, de Leeuw E]
通讯作者:
de Leeuw E
DOI:
10.1371/journal.ppat.1003732
发表时间:
2013
期刊:
PLoS pathogens
影响因子:
6.7
作者:
[Varney KM, Bonvin AM, Pazgier M, Malin J, Yu W, Ateh E, Oashi T, Lu W, Huang J, Diepeveen-de Buin M, Bryant J, Breukink E, Mackerell AD Jr, de Leeuw EP]
通讯作者:
de Leeuw EP
Effect of a small molecule Lipid II binder on bacterial cell wall stress.
小分子脂质 II 结合剂对细菌细胞壁应激的影响。
DOI:
10.2147/idr.s126254
发表时间:
2017
期刊:
Infection and drug resistance
影响因子:
3.9
作者:
[Malin,Jakob, Shetty,AmolC, Daugherty,SeanC, deLeeuw,ErikPh]
通讯作者:
deLeeuw,ErikPh
Molecular Basis of Human Defensins as Novel Lipid II Binding Peptide Antibiotics
-
批准号:8191604
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2011
-
负责人:Erik de Leeuw
-
依托单位:
海外基金